Re: Diagnosis and Management of Nocturia in Current Clinical Practice: Who are Nocturia Patients, and How do we Treat Them?
- 1 December 2019
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 202 (6), 1104-1105
- https://doi.org/10.1097/01.ju.0000585428.92284.40
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Determinants of Nocturia: the Krimpen StudyJournal of Urology, 2014
- A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysisEuropean Urology, 2012
- Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double‐blind, placebo‐controlled trialNeurourology and Urodynamics, 2012
- Nocturia Frequency, Bother, and Quality of Life: How Often Is Too Often? A Population-Based Study in FinlandEuropean Urology, 2010
- Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled StudyEuropean Urology, 2007
- Changes in Nocturia From Medical Treatment of Benign Prostatic Hyperplasia: Secondary Analysis of the Department of Veterans Affairs Cooperative Study TrialJournal of Urology, 2003